Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disturbance; Vision, Loss”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07073521
What this trial is testing

Developing Evidence-Based Cognitive Approaches to Improve Adjustment to Vision Loss

Who this might be right for
Depression, AnxietyVisual ImpairmentAdjustment+5 more
The Chicago Lighthouse 45
Post-approval studies (Phase 4)Active Not RecruitingNCT06970665
What this trial is testing

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc 17
Not applicableEnrolling By InvitationNCT07559292
What this trial is testing

Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes

Who this might be right for
Vision DisordersDiabetes
University of Wisconsin, Madison 1,700
Not applicableNot Yet RecruitingNCT07216924
What this trial is testing

Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss

Who this might be right for
Macular DegenerationCentral Visual Impairment
University of Minnesota 100
Not applicableStudy completedNCT06176625
What this trial is testing

Sight and Hearing Investigation Into Effects on Delirium

Who this might be right for
Hearing LossHearing Loss, Age-RelatedHearing Disability+14 more
Johns Hopkins University 1,543
Early research (Phase 1)Study completedNCT04925687
What this trial is testing

Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
University of California, Davis 4
Not applicableUnknownNCT05765162
What this trial is testing

Safe Brain Initiative, Operationalizing Precision Anaesthesia

Who this might be right for
Neurocognitive DisordersPost Operative DeliriumPain+14 more
University of Southern Denmark 15,000
Early research (Phase 1)Active Not RecruitingNCT01736059
What this trial is testing

Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy

Who this might be right for
Non-exudative Age-related Macular DegenerationDiabetic RetinopathyRetina Vein Occlusion+2 more
University of California, Davis 15
Not applicableLooking for participantsNCT07341763
What this trial is testing

Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment

Who this might be right for
Retinitis Pigmentosa (RP)Rod Cone DystrophyVisually Impaired Persons+8 more
University of Waterloo 20
Not applicableStudy completedNCT05456581
What this trial is testing

Scotoma Perimetry Oculomotor Training

Who this might be right for
Macular DegenerationCentral Visual Impairment
University of Alabama at Birmingham 21
Not applicableLooking for participantsNCT06121219
What this trial is testing

Effect of Visual Retraining After Stroke

Who this might be right for
Vision Loss PartialVision; Loss, Both EyesHemianopia Homonymous+5 more
University of Rochester 100
Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Not applicableStudy completedNCT05098236
What this trial is testing

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Who this might be right for
Vision Loss PartialHemianopiaHemianopia Homonymous+2 more
University of Rochester 280
Testing effectiveness (Phase 2)Looking for participantsNCT02521311
What this trial is testing

Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)

Who this might be right for
Optic Neuritis
University of California, San Francisco 90
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableWithdrawnNCT06352086
What this trial is testing

Understanding Visual Processing After Occipital Stroke

Who this might be right for
Vision Loss PartialVision; Loss, Both EyesHemianopia, Homonymous+7 more
University of Rochester
Large-scale testing (Phase 3)Not Yet RecruitingNCT05909488
What this trial is testing

Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II

Who this might be right for
Retinitis Pigmentosa
PT. Prodia Stem Cell Indonesia 30
Not applicableActive Not RecruitingNCT02500862
What this trial is testing

Characterization of Potential Biomarkers of Eye Disease and Vision

Who this might be right for
Eye Disease
Association for Innovation and Biomedical Research on Light and Image 100
Not applicableStudy completedNCT01983488
What this trial is testing

Clinical Outcome in Uveitis

Who this might be right for
Uveitis
Moorfields Eye Hospital NHS Foundation Trust 231
Next Page